Abstract Details

Title Intravenous Immunoglobulin (IVIg) Treatment Causes Dose-Dependent Alterations in [beta]-Amyloid (A[beta]) Levels and Anti-A[beta] Antibody Titers in Plasma and Cerebrospinal Fluid (CSF) of Alzheimer's Disease (AD) Patients

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 002

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Aaron R. Switzer, MSc (University of Calgary)	Dr. Switzer has nothing to disclose.
	No disclosure on file
Ikreet Cheema, MD	No disclosure on file
	No disclosure on file
Silvia Presas	Silvia Presas has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Sandra Serrano	No disclosure on file
	No disclosure on file
Cristina M. Ramo, MD (Hospital Germans Trias I Pujol)	Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
	No disclosure on file
	No disclosure on file